Market Closed -
Nyse
04:00:02 2024-05-15 pm EDT
5-day change
1st Jan Change
74.54
USD
+2.86%
+7.41%
-31.93%
Ex-dividend day
A dividend is removed today from 's share.
Wells Fargo Adjusts Price Target on CONMED to $77 From $98, Maintains Equalweight Rating
Apr. 25
MT
Needham Lowers Price Target on CONMED to $107 From $129, Notes Slight Guidance Cut Due to Currency, Keeps Buy Rating
Apr. 25
MT
Transcript : CONMED Corporation, Q1 2024 Earnings Call, Apr 24, 2024
Apr. 24
Earnings Flash (CNMD) CONMED CORPORATION Posts Q1 Revenue $312.3M, vs. Street Est of $306.7M
Apr. 24
MT
CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer
Apr. 24
CI
CONMED Corporation Revises Earnings Guidance for the Full Year 2024
Apr. 24
CI
CONMED Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
Apr. 24
CI
CONMED Corporation Announces Not Stand for Re-Election of Jerome Lande as Director
Apr. 08
CI
CONMED Corporation Declares Quarterly Cash Dividend, Payable on April 5, 2024
Feb. 27
CI
Sector Update: Health Care Stocks Rise in Late Afternoon
Feb. 01
MT
CONMED Shares Fall After Q4 Results Trail Analyst Estimates
Feb. 01
MT
Needham Adjusts Price Target on CONMED to $129 From $119, Maintains Buy Rating
Feb. 01
MT
JPMorgan Cuts CONMED Price Target to $115 From $135, Maintains Overweight Rating
Feb. 01
MT
CONMED Q4 Adjusted Earnings, Net Sales Rise; Sets 2024 Outlook; Shares Drop
Jan. 31
MT
Transcript : CONMED Corporation, Q4 2023 Earnings Call, Jan 31, 2024
Jan. 31
CONMED Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
Jan. 31
CI
Earnings Flash (CNMD) CONMED CORPORATION Posts Q4 Revenue $327M, vs. Street Est of $332.2M
Jan. 31
MT
CONMED Corporation Provides Financial Guidance for the Full Year 2024
Jan. 31
CI
CONMED Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Jan. 31
CI
Transcript : CONMED Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 02:15 PM
Jan. 08
Conmed Insider Sold Shares Worth $252,833, According to a Recent SEC Filing
Dec. 06
MT
CONMED Keeps Quarterly Dividend at $0.20 a Share, Payable Jan. 5 to Shareholders of Record Dec. 18
Dec. 05
MT
CONMED Corporation Announces Quarterly Cash Dividend, Payable on January 5, 2024
Dec. 05
CI
Conmed Insider Sold Shares Worth $122,874, According to a Recent SEC Filing
Nov. 09
MT
Piper Sandler Adjusts Price Target on CONMED to $130 From $145, Maintains Overweight Rating
23-10-27
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
More about the company
Last Close Price
74.54
USD
Average target price
92.38
USD
Spread / Average Target
+23.93%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**
-40% Limited Time Offer : Our subscriptions help you unlock hidden opportunities.**#000000**/services/solutions/**#fff826**#ff3000**#ffffff**
BENEFIT NOW **0**linear-gradient(180deg, rgba(42,73,76,1) 0%, rgba(28,30,51,1) 53%);**linear-gradient(180deg, rgba(255, 248, 38,1) 0%, rgba(247, 239,1) 53%);**date_fin_hors_prolongation**49**on all our subscriptions**